ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS
Clinical trials for ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS explained in plain language.
Never miss a new study
Get alerted when new ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS trials appear
Sign up with your email to follow new studies for ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New lung-scope treatment aims to clear mucus and fight fungus in ABPA patients
Disease control Recruiting nowThis study is for people with allergic bronchopulmonary aspergillosis (ABPA), a lung condition caused by a fungus. Researchers want to see if cleaning mucus plugs from the airways with a bronchoscope and spraying an antifungal drug (amphotericin B) is safe and effective. About 44…
Matched conditions: ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS
Sponsor: Qianfoshan Hospital • Aim: Disease control
Last updated May 17, 2026 06:18 UTC
-
New biologic drugs aim to tame rare lung allergy in severe asthma patients
Disease control Recruiting nowThis study looks at whether biologic drugs can safely reduce flare-ups in people with allergic bronchopulmonary aspergillosis (ABPA), a lung condition caused by an allergic reaction to a common mold. About 50 adults with severe asthma and a history of asthma attacks will receive …
Matched conditions: ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS
Sponsor: Qianfoshan Hospital • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
New shot may tame severe asthma and fungal lung allergy
Disease control Recruiting nowThis study tests a drug called benralizumab for people with severe asthma and a fungal lung condition called ABPA. The goal is to see if it can reduce the number of asthma attacks that need steroids and improve quality of life. About 20 adults will take part. This is not a cure, …
Matched conditions: ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS
Sponsor: Qianfoshan Hospital • Aim: Disease control
Last updated May 12, 2026 13:42 UTC
-
Fungus lung disease: which drug combo works best?
Disease control Recruiting nowThis study looks at people with a mix of two lung conditions caused by the Aspergillus fungus. It compares taking one antifungal drug (itraconazole) alone versus taking it with steroids. The goal is to see which approach leads to better symptom control and lung health after 6 and…
Matched conditions: ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS
Phase: NA • Sponsor: Post Graduate Institute of Medical Education and Research, Chandigarh • Aim: Disease control
Last updated May 11, 2026 20:41 UTC